Table 4.
Population | BHT | HCC | Sen | Spec | Prec | Recall | F-M | AUC | |
---|---|---|---|---|---|---|---|---|---|
All | n | 32 | 32 | 87.50% | 93.75% | 93.33% | 87.50% | 90.32% | 94.43% |
Mean | 1.66 | 0.65 | |||||||
SD | 0.57 | 0.41 | |||||||
p value | 0.000000000023 | ||||||||
95% CI | 0.76–1.26 | ||||||||
Female | n | 11 | 11 | 81.82% | 81.82% | 81.82% | 81.82% | 81.82% | 93.39% |
Mean | 1.85 | 0.65 | |||||||
SD | 0.69 | 0.39 | |||||||
p value | 0.000067 | ||||||||
95% CI | 0.70–1.69 | ||||||||
Male | n | 21 | 21 | 90.48% | 95.24% | 95.00% | 90.48% | 92.68% | 95.24% |
Mean | 1.56 | 0.65 | |||||||
SD | 0.48 | 0.43 | |||||||
p value | 0.00000011 | ||||||||
95% CI | 0.62–1.19 |
BHT benign hepatic tissue, HCC hepatocellular carcinoma, Sen sensitivity, Spec specificity, Prec precision; F-M F measurement, AUC area under curve